Thomas J. PetoMark DebackereWilliam EtienneLieven VernaeveRupam TripuraGregoire FalqChan DavoeungChea NguonHuy RekolLorenz Von SeidleinArjen M. DondorpNou SanannPhaik Yeong CheahMartin De SmetChristopher PellJean Marie KindermansMedecins Sans Frontieres, BrusselsMahidol UniversityNuffield Department of Clinical MedicineUniversity of AmsterdamAmsterdam UMC - University of AmsterdamCentre for Parasitology, Entomology and Malaria ControlAmsterdam Institute for Global Health and DevelopmentProvincial Health Department2019-08-232019-08-232018-01-27Malaria Journal. Vol.17, No.1 (2018)147528752-s2.0-85041117924https://repository.li.mahidol.ac.th/handle/20.500.14594/46052© 2018 The Author(s). Two mass drug administrations (MDA) against falciparum malaria were conducted in 2015-16, one as operational research in northern Cambodia, and the other as a clinical trial in western Cambodia. During an April 2017 workshop in Phnom Penh the field teams from Médecins Sans Frontières and the Mahidol-Oxford Tropical Medicine Research Unit discussed lessons for future MDAs.Mahidol UniversityImmunology and MicrobiologyMedicineConference PaperSCOPUS10.1186/s12936-018-2202-z